<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>GO_Annotation</source><date>20130316</date><key>go_annotation.key</key><document><id>16987298</id><passage><infon key="type">paragraph</infon><offset>21171</offset><annotation id="16987298_1"><infon key="gene">Fas(246097)</infon><infon key="go-term">response to organic cyclic compound|GO:0014070</infon><infon key="goevidence">IEP</infon><infon key="type">GOA</infon><location offset="21273" length="171"/><text>Results showed that BP significantly induced Fas expression (from one to 41.3-fold vs. one to 7.7-fold in DBTRG-05MG and RG2 cells, respectively) but not Fas-L expression.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>21748</offset><annotation id="16987298_2"><infon key="gene">Casp3(25402)</infon><infon key="go-term">cellular response to organic cyclic compound|GO:0071407</infon><infon key="goevidence">IEP</infon><infon key="type">GOA</infon><location offset="21839" length="116"/><text>Both procaspase 9 and procaspase 3 were highly activated in DBTRG-05MG, DBTRG 8401 and RG2 cells after BP treatment.</text></annotation><annotation id="16987298_3"><infon key="gene">Casp9(58918)</infon><infon key="go-term">cellular response to organic cyclic compound|GO:0071407</infon><infon key="goevidence">IEP</infon><infon key="type">GOA</infon><location offset="21839" length="116"/><text>Both procaspase 9 and procaspase 3 were highly activated in DBTRG-05MG, DBTRG 8401 and RG2 cells after BP treatment.</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>22035</offset><annotation id="16987298_4"><infon key="gene">Casp3(25402)</infon><infon key="go-term">response to organic cyclic compound|GO:0014070</infon><infon key="goevidence">IEP</infon><infon key="type">GOA</infon><location offset="22965" length="139"/><text>and the results showed that BP treatment increased the cleavage of caspase 3 protein to induce apoptosis of tumor cells in vivo (Fig. 3d). </text></annotation></passage><passage><infon key="type">paragraph</infon><offset>24595</offset><annotation id="16987298_5"><infon key="gene">Mki67(291234)</infon><infon key="go-term">response to organic cyclic compound|GO:0014070</infon><infon key="goevidence">IEP</infon><infon key="type">GOA</infon><location offset="25221" length="253"/><text>The immunohistochemistry results on day 16 after BP treatment showed a decrease in Ki-67 protein expression, an increase in cleaved caspase 3 protein expression and an increase in apoptosis in tumor cells relative to the control group in vivo (Fig. 4c);</text></annotation><annotation id="16987298_6"><infon key="gene">Casp3(25402)</infon><infon key="go-term">response to organic cyclic compound|GO:0014070</infon><infon key="goevidence">IEP</infon><infon key="type">GOA</infon><location offset="25221" length="253"/><text>The immunohistochemistry results on day 16 after BP treatment showed a decrease in Ki-67 protein expression, an increase in cleaved caspase 3 protein expression and an increase in apoptosis in tumor cells relative to the control group in vivo (Fig. 4c);</text></annotation><annotation id="16987298_7"><infon key="gene">Casp3(25402)</infon><infon key="go-term">cellular response to organic cyclic compound|GO:0071407</infon><infon key="goevidence">IEP</infon><infon key="type">GOA</infon><location offset="25221" length="253"/><text>The immunohistochemistry results on day 16 after BP treatment showed a decrease in Ki-67 protein expression, an increase in cleaved caspase 3 protein expression and an increase in apoptosis in tumor cells relative to the control group in vivo (Fig. 4c);</text></annotation><annotation id="16987298_8"><infon key="gene">Mki67(291234)</infon><infon key="go-term">cellular response to organic cyclic compound|GO:0071407</infon><infon key="goevidence">IEP</infon><infon key="type">GOA</infon><location offset="25221" length="253"/><text>The immunohistochemistry results on day 16 after BP treatment showed a decrease in Ki-67 protein expression, an increase in cleaved caspase 3 protein expression and an increase in apoptosis in tumor cells relative to the control group in vivo (Fig. 4c);</text></annotation></passage><passage><infon key="type">paragraph</infon><offset>34957</offset><annotation id="16987298_9"><infon key="gene">Casp9(58918)</infon><infon key="go-term">cellular response to organic cyclic compound|GO:0071407</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="35199" length="135"/><text>However, although RG2 cells were impaired for p53 and p16, p27 and procaspase 9 expression induced by BP were increased in these cells.</text></annotation><annotation id="16987298_10"><infon key="gene">Cdkn1b(83571)</infon><infon key="go-term">cellular response to organic cyclic compound|GO:0071407</infon><infon key="goevidence">NONE</infon><infon key="type">GOA</infon><location offset="35199" length="135"/><text>However, although RG2 cells were impaired for p53 and p16, p27 and procaspase 9 expression induced by BP were increased in these cells.</text></annotation></passage></document></collection>
